ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators.Journal of cancer survivorship : research and practice · 2026Article
- Clinical and social determinants of sustained head and neck cancer survivorship clinic attendance.Journal of cancer survivorship : research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposeParticipation rates in cancer survivorship care (CSC) programs are suboptimal and reasons for non-attendance are poorly understood. To identify possible improvements of the Dutch CSC for Hodgkin lymphoma (HL) survivors, we aimed to (1) identify survivor and treatment characteristics associated with non-attendance at Dutch CSC clinics for HL survivors and (2) evaluate reasons for non-attendance.
methodsIn a retrospective multicenter cohort study, we assessed attendance among 516 adult HL survivors invited to eight CSC clinics from 2013 to 2024. The associations between sex, socio-economic status, age at CSC invitation, HL treatment category, history of cardiovascular disease, history of subsequent malignancy, time since HL diagnosis, and non-attendance were assessed in multivariable logistic regression analysis. Reasons for non-attendance were retrieved from a survey sent to all non-attenders.
resultsCSC attendance was 70% (n = 363). In multivariable analysis, male sex was associated with higher odds of non-attendance compared to female sex (odds ratio (OR) 1.61, 95% confidence interval (CI) 1.01-2.56) while a history of subsequent malignancy was associated with lower odds of non-attendance (OR 0.41, 95% CI 0.19-0.89). Of all non-attenders, 44 (28.8%, of whom 45.5% male) responded to the survey. Frequently reported reasons for non-attendance were surveillance or treatment for late effects elsewhere (n = 17) and emotional burden of clinic visit (n = 15).
conclusionOur findings inform attempts to improve attendance at Dutch CSC clinics for HL survivors. Active involvement of healthy (male) survivors in improvement of the survivorship program is key to its success.
Indexed as
Identifiers
40473923What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.